News
22.03.2022
AZ Biopharm published a guest article in the FAZ on the future of the cannabis business in Germany after the release by the German government
“The coalition agreement of the SPD, Green party and FDP provides for the controlled supply of cannabis to adults for recreational purposes and a permit for cultivation for commercial purposes. With this newly created availability comes the need to systematically analyze and regulate cannabis products to protect consumers from pesticides, biological contaminants and heavy metals. As a certified laboratory, the Berlin-based testing laboratory AZ Biopharm will play a central role in the testing of large batches of cannabis in the future. In this article, the managing directors Dr. Martin Reinsch and Dr. Berthold Lausecker give an overview of the current situation of legalization, the need for exact analysis and possibilities for testing cannabis products.”
Link to the article: AZ Biopharm -Firmen FAZ.net
-
- Dr. Martin Reinsch,
Managing director AZ-Biopharm
-
- Dr. Berthold Lausecker,
Managing director AZ-Biopharm
